Dermata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.About DRMA
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerald T. Proehl
CEOGerald T. Proehl
Employees8
Employees8
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees8
Employees8
DRMA Key Statistics
Market cap3.91M
Market cap3.91M
Price-Earnings ratio-0.15
Price-Earnings ratio-0.15
Dividend yield—
Dividend yield—
Average volume23.78K
Average volume23.78K
High today$5.74
High today$5.74
Low today$5.14
Low today$5.14
Open price$5.15
Open price$5.15
Volume27.00K
Volume27.00K
52 Week high$24.90
52 Week high$24.90
52 Week low$5.09
52 Week low$5.09
DRMA News
TipRanks 6d
Dermata Therapeutics Regains Nasdaq Compliance by August 2025Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.